Liminal BioSciences Inc.
LMNL · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $19 | $27 | $37 | $41 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $1 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $3 | $2 |
| Total Curr. Assets | $26 | $34 | $41 | $44 |
| Property Plant & Equip (Net) | $1 | $1 | $5 | $6 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1 | $1 | $3 | $1 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $6 | $5 | $9 | $10 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $32 | $39 | $50 | $54 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $3 | $0 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $9 | $8 | $6 | $8 |
| Total Curr. Liab. | $9 | $9 | $10 | $9 |
| LT Debt | $1 | $1 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $0 | $3 | $4 |
| Total NC Liab. | $1 | $1 | $4 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $10 | $10 | $14 | $13 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $981 | $980 | $980 | $980 |
| Retained Earnings | -$1,099 | -$1,090 | -$1,082 | -$1,078 |
| AOCI | -$3 | -$3 | -$3 | -$3 |
| Other Equity | $142 | $142 | $142 | $142 |
| Total Equity | $21 | $29 | $36 | $40 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $32 | $39 | $50 | $54 |
| Net Debt | -$18 | -$26 | -$36 | -$39 |